151 related articles for article (PubMed ID: 36939129)
21. An update on the implications of cyclin D1 in melanomas.
González-Ruiz L; González-Moles MÁ; González-Ruiz I; Ruiz-Ávila I; Ayén Á; Ramos-García P
Pigment Cell Melanoma Res; 2020 Nov; 33(6):788-805. PubMed ID: 32147907
[TBL] [Abstract][Full Text] [Related]
22. Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridization.
Busam KJ; Fang Y; Jhanwar SC; Pulitzer MP; Marr B; Abramson DH
J Cutan Pathol; 2010 Feb; 37(2):196-203. PubMed ID: 20100177
[TBL] [Abstract][Full Text] [Related]
23. Molecular testing of borderline cutaneous melanocytic lesions: SNP array is more sensitive and specific than FISH.
Carter MD; Durham AB; Miedema JR; Harms PW; Chan MP; Patel RM; Lowe L; Fullen DR; Hristov AC; Wang M; Andea AA
Hum Pathol; 2019 Apr; 86():115-123. PubMed ID: 30576704
[TBL] [Abstract][Full Text] [Related]
24. Spitzoid tumors in children and adults: a comparative clinical, pathological, and cytogenetic analysis.
Dika E; Fanti PA; Fiorentino M; Capizzi E; Neri I; Piraccini BM; Ravaioli GM; Misciali C; Passarini B; Patrizi A
Melanoma Res; 2015 Aug; 25(4):295-301. PubMed ID: 25933206
[TBL] [Abstract][Full Text] [Related]
25. A Novel Method to Detect Copy Number Variation in Melanoma: Droplet Digital PCR for Quantitation of the CDKN2A Gene, a Proof-of-Concept Study.
McFadden JR; Syku M; Barney RE; Stevanovic M; Chaudhari AS; O'Hern KJ; Chambers M; Baker CM; LeBlanc RE; Doan L; Tsongalis GJ; Hughes EG; Sriharan A
Am J Dermatopathol; 2023 Jul; 45(7):454-462. PubMed ID: 37130203
[TBL] [Abstract][Full Text] [Related]
26. Single Time Frame Overview of the Genetic Changes in Conjunctival Melanoma from Intraepithelial Disease to Invasive Melanoma: A Study of 4 Exenteration Specimens Illustrating the Potential Role of Cyclin D1.
Mudhar HS; Salvi SS; Pissaloux D; de La Fouchardiere A
Ocul Oncol Pathol; 2022 Feb; 8(1):52-63. PubMed ID: 35356600
[TBL] [Abstract][Full Text] [Related]
27. Detecting copy number alterations of oncogenes in cell-free DNA to monitor treatment response in acral and mucosal melanoma.
Mikoshiba A; Ashida A; Sakaizawa K; Kiniwa Y; Okuyama R
J Dermatol Sci; 2020 Mar; 97(3):172-178. PubMed ID: 31987696
[TBL] [Abstract][Full Text] [Related]
28. Fluorescence in situ hybridization for the differential diagnosis between Spitz naevus and spitzoid melanoma.
Requena C; Rubio L; Traves V; Sanmartín O; Nagore E; Llombart B; Serra C; Fernández-Serra A; Botella R; Guillén C
Histopathology; 2012 Nov; 61(5):899-909. PubMed ID: 22882594
[TBL] [Abstract][Full Text] [Related]
29. [Biological role and prognostic significance of genetic alterations in human malignant melanomas].
Vízkeleti L
Magy Onkol; 2015 Sep; 59(3):268-72. PubMed ID: 26339916
[TBL] [Abstract][Full Text] [Related]
30. Distinguishing epithelioid blue nevus from blue nevus-like cutaneous melanoma metastasis using fluorescence in situ hybridization.
Pouryazdanparast P; Newman M; Mafee M; Haghighat Z; Guitart J; Gerami P
Am J Surg Pathol; 2009 Sep; 33(9):1396-400. PubMed ID: 19606012
[TBL] [Abstract][Full Text] [Related]
31. Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions.
Harms PW; Hocker TL; Zhao L; Chan MP; Andea AA; Wang M; Harms KL; Wang ML; Carskadon S; Palanisamy N; Fullen DR
Hum Pathol; 2016 Dec; 58():152-160. PubMed ID: 27569296
[TBL] [Abstract][Full Text] [Related]
32. Classifying ambiguous melanocytic lesions with FISH and correlation with clinical long-term follow up.
Gaiser T; Kutzner H; Palmedo G; Siegelin MD; Wiesner T; Bruckner T; Hartschuh W; Enk AH; Becker MR
Mod Pathol; 2010 Mar; 23(3):413-9. PubMed ID: 20081813
[TBL] [Abstract][Full Text] [Related]
33. Fluorescence in-situ hybridization and dermoscopy in the assessment of controversial melanocytic tumors.
Ponti G; Ruini C; Massi D; Pellacani G; Tomasi A; Paglierani M; Loschi P; Seidenari S
Melanoma Res; 2013 Dec; 23(6):474-80. PubMed ID: 24077512
[TBL] [Abstract][Full Text] [Related]
34. Classifying melanocytic tumors based on DNA copy number changes.
Bastian BC; Olshen AB; LeBoit PE; Pinkel D
Am J Pathol; 2003 Nov; 163(5):1765-70. PubMed ID: 14578177
[TBL] [Abstract][Full Text] [Related]
35. Role of ROC1 protein in the control of cyclin D1 protein expression in skin melanomas.
Nai G; Marques M
Pathol Res Pract; 2011 Mar; 207(3):174-81. PubMed ID: 21300445
[TBL] [Abstract][Full Text] [Related]
36. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi.
Gerami P; Wass A; Mafee M; Fang Y; Pulitzer MP; Busam KJ
Am J Surg Pathol; 2009 Dec; 33(12):1783-8. PubMed ID: 19809275
[TBL] [Abstract][Full Text] [Related]
37. Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics.
Magro CM; Abraham RM; Guo R; Li S; Wang X; Proper S; Crowson AN; Mihm M
Eur J Dermatol; 2014; 24(5):594-602. PubMed ID: 25118781
[TBL] [Abstract][Full Text] [Related]
38. Fluorescence In Situ Hybridization for Melanoma Diagnosis: A Review and a Reappraisal.
Ferrara G; De Vanna AC
Am J Dermatopathol; 2016 Apr; 38(4):253-69. PubMed ID: 26999337
[TBL] [Abstract][Full Text] [Related]
39. Anatomic site-specific patterns of gene copy number gains in skin, mucosal, and uveal melanomas detected by fluorescence in situ hybridization.
Glatz-Krieger K; Pache M; Tapia C; Fuchs A; Savic S; Glatz D; Mihatsch M; Meyer P
Virchows Arch; 2006 Sep; 449(3):328-33. PubMed ID: 16523260
[TBL] [Abstract][Full Text] [Related]
40. Presence of cytogenetic abnormalities in Spitz naevi: a diagnostic challenge for fluorescence in-situ hybridization analysis.
Martin V; Banfi S; Bordoni A; Leoni-Parvex S; Mazzucchelli L
Histopathology; 2012 Jan; 60(2):336-46. PubMed ID: 22211292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
